Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Annals of Burns and Fire Disasters
|
June 3, 2016
Development of an effective communication strategy for the prevention of burns in children: the PRIUS project
S Cedri, E Briguglio, C Cedri, et al.
Annals of Burns and Fire Disasters
|
October 13, 2011
The use of osseointegrated epistheses in severe face burn sequelae
M M Ferrara, V Cervelli, D J Bottini, et al.
Leukemia
|
January 1, 1993
Homotypic aggregation of pre-B leukemic cell lines by antibodies to VLA integrins correlates with their expression of CD9
M Letarte, J G Seehafer, A Greaves, et al.
Leukemia & Lymphoma
|
August 1, 1996
Circulating clonotypic B cells in the biology of multiple myeloma: speculations on the origin of myeloma
L M Pilarski, A Masellis-Smith, A Szczepek, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 1, 1990
Anti-CD9 monoclonal antibodies induce homotypic adhesion of pre-B cell lines by a novel mechanism
A Masellis-Smith, G S Jensen, J G Seehafer, et al.
The Journal of Biological Chemistry
|
July 25, 1989
Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb-IIIa complex
J R Slupsky, J G Seehafer, S C Tang, et al.
Blood
|
March 1, 1996
Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44
A Masellis-Smith, A R Belch, M J Mant, et al.
Biochimica Et Biophysica Acta
|
June 19, 1990
Myristic acid is incorporated into the two acylatable domains of the functional glycoprotein CD9 in ester, but not in amide bonds
J G Seehafer, J R Slupsky, S C Tang, et al.
Leukemia & Lymphoma
|
August 1, 1994
RHAMM, a receptor for hyaluronan-mediated motility, on normal human lymphocytes, thymocytes and malignant B cells: a mediator in B cell malignancy?
L M Pilarski, A Masellis-Smith, A R Belch, et al.
Leukemia
|
September 18, 2009
A phase I/II trial of TLR-7 agonist immunotherapy in chronic lymphocytic leukemia
D E Spaner, Y Shi, D White, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Annals of Burns and Fire Disasters
|
June 3, 2016
Development of an effective communication strategy for the prevention of burns in children: the PRIUS project
S Cedri, E Briguglio, C Cedri, et al.
Annals of Burns and Fire Disasters
|
October 13, 2011
The use of osseointegrated epistheses in severe face burn sequelae
M M Ferrara, V Cervelli, D J Bottini, et al.
Leukemia
|
January 1, 1993
Homotypic aggregation of pre-B leukemic cell lines by antibodies to VLA integrins correlates with their expression of CD9
M Letarte, J G Seehafer, A Greaves, et al.
Leukemia & Lymphoma
|
August 1, 1996
Circulating clonotypic B cells in the biology of multiple myeloma: speculations on the origin of myeloma
L M Pilarski, A Masellis-Smith, A Szczepek, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 1, 1990
Anti-CD9 monoclonal antibodies induce homotypic adhesion of pre-B cell lines by a novel mechanism
A Masellis-Smith, G S Jensen, J G Seehafer, et al.
The Journal of Biological Chemistry
|
July 25, 1989
Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb-IIIa complex
J R Slupsky, J G Seehafer, S C Tang, et al.
Blood
|
March 1, 1996
Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44
A Masellis-Smith, A R Belch, M J Mant, et al.
Biochimica Et Biophysica Acta
|
June 19, 1990
Myristic acid is incorporated into the two acylatable domains of the functional glycoprotein CD9 in ester, but not in amide bonds
J G Seehafer, J R Slupsky, S C Tang, et al.
Leukemia & Lymphoma
|
August 1, 1994
RHAMM, a receptor for hyaluronan-mediated motility, on normal human lymphocytes, thymocytes and malignant B cells: a mediator in B cell malignancy?
L M Pilarski, A Masellis-Smith, A R Belch, et al.
Leukemia
|
September 18, 2009
A phase I/II trial of TLR-7 agonist immunotherapy in chronic lymphocytic leukemia
D E Spaner, Y Shi, D White, et al.
Page
of 3